Press release
Campylobacter Diagnostics Market Value Projected to Expand by 2025
Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables. Major symptoms of campylobacter infection include diarrhea, blood and mucus in stool, malaise, severe abdominal pain, nausea, fever, vomiting, and headache. On average, campylobacter infection lasts from two to 10 days. Campylobacter infection is diagnosed through laboratory tests of stool, body fluids, or tissue. Two types of tests are commonly performed: rapid test (analyzes the genetic material of campylobacter bacteria) and culture test (isolation of bacteria). Majorly, people affected with campylobacter infection are treated with antibiotics.The global Campylobacter Diagnostics Market is driven by several factors such as rise in population, sense of hygiene, diagnosis rate, cost of campylobacter infection diagnostic test, health care expenditure scenario, and presence of key market players. A study published in the Journal of Clinical Microbiology in 2016 revealed that the isolation and identification of the campylobacter infection from stool sample is the most challenging part in the campylobacter diagnosis test. Therefore, this market is likely to face challenges from sequencing of genetic materials of campylobacter infection, and un-automated data analysis during campylobacter detection method. R&D investments and technological advancements are likely to boost the growth of the global campylobacter diagnosis market during the forecast period.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39584
Culture-based detection method is used to isolate and detect campylobacter infection from the sample. This method is cost-effective and requires no sophisticated instrument; however, it is time-consuming and has low-sensitivity. Rapid detection tests such as immunological or molecular techniques offer accurate result of campylobacter bacteria, although those tests are expensive as compared to culture based detection. Based on diagnosis method, the global campylobacter diagnosis market can be segmented into culture based diagnosis and rapid detection tests. Furthermore, the rapid detection tests can be segmented into immunological, molecular, and other methods. In terms of end-user, the market can be classified into hospitals, private laboratories, independent physician chambers, and others.
Geographically, the global campylobacter diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Control and Prevention, an estimated 1.3 million people were affected with campylobacter infection in the U.S. in 2016. Nearly 200,000 confirmed cases were reported in Europe in 2014, with crude notification rate of 59.8 cases per 100,000 (reflecting an increase of 13% of the campylobacter notification rate in 2014 as compared to 2013). Significant infection rate, high diagnosis rate of campylobacter infection, well-established health care infrastructure, availability of medical reimbursement, and strong presence of key companies are likely to boost the growth of North America and Europe campylobacter diagnostics market in future. Several studies indicate that a significant number of people are affected by campylobacter infection in Asia Pacific.
Request to View ToC of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39584
Around 5% to 15% of the total gastrointestinal cases in India and China in 2016 were campylobacter affected cases due to low sense of hygiene and poor sanitary system. The picture is quite shocking in Australia and New Zealand. Around 112.3 to 150.0 cases per 100,000 per year were affected in Australia and New Zealand in 2016. High number of campylobacter infected cases, developing medical infrastructure, high investment, and presence of key companies in Asia Pacific drive the campylobacter diagnostics market. Low awareness about campylobacter infection diagnosis and unfavorable medical reimbursements are the factors attributed to sluggish growth of the market in Latin America and Middle East & Africa.
Key players in the global campylobacter diagnostics market include Becton, Dickinson and Company, Meridian Bioscience, Inc., Thermo Fisher Scientific, BIOTECON Diagnostics, Agilent Technologies, Alere, QIAGEN, Roche Molecular Systems, Inc., Siemens Healthineers, Lonza, ZeptoMetrix, and Sequenom.
View Report -
https://www.transparencymarketresearch.com/campylobacter-diagnostics-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Campylobacter Diagnostics Market Value Projected to Expand by 2025 here
News-ID: 973266 • Views: …
More Releases from Transparency Market Research

Non-Invasive Cancer Diagnostics Market to Hit USD 207 Billion by 2031, Driven by …
The global non-invasive cancer diagnostics market is experiencing significant growth, fueled by an increasing demand for early and painless cancer detection methods. Non-invasive diagnostic technologies, such as liquid biopsies, imaging techniques, and molecular diagnostics, are gaining widespread acceptance as they offer accurate, rapid, and patient-friendly alternatives to traditional biopsy-based procedures.
The global non-invasive cancer diagnostics market is projected to reach a valuation of USD 207 billion by 2031, growing at a…

Peripheral Arterial Disease Treatment Market to Reach USD 6.4 Billion by 2035, G …
The global Peripheral Arterial Disease (PAD) Treatment Market is poised for substantial evolution over the next decade, driven by an aging population, rising incidences of lifestyle-related vascular disorders, and technological innovations in treatment methodologies. Peripheral arterial disease, a condition characterized by narrowed arteries reducing blood flow to the limbs, affects millions worldwide and is often underdiagnosed. As awareness and diagnostic capabilities improve, the demand for effective treatment modalities continues to…

Veterinary CRO Market Outlook 2035: CAGR of 7.1% Predicted as Innovation and Col …
The global Veterinary Contract Research Organization (CRO) market, currently valued at US$ 770.8 million in 2024, is poised for substantial expansion. According to industry projections, the market is expected to grow at a robust CAGR of 7.1% between 2025 and 2035, reaching a valuation of over US$ 1.6 billion by the end of the forecast period. Key drivers of this growth include an increase in pet ownership, rising demand for…

Carrier Screening Market Set for 11.8% CAGR Growth Through 2035, Fueled by Techn …
The global carrier screening market continues to exhibit robust growth, driven by advancements in genomics, increased awareness of inherited genetic disorders, and rising demand for early disease detection. Valued at US$ 1.7 billion in 2024, the market is expected to grow at a compound annual growth rate (CAGR) of 11.8% between 2025 and 2035, reaching a projected value of US$ 5.8 billion by 2035.
Leading market participants such as Myriad Genetics,…
More Releases for Campylobacter
Campylobacter Infections Market to Witness Growth by 2032, Estimates DelveInsigh …
DelveInsight's "Campylobacter Infections Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Campylobacter Infections, historical and forecasted epidemiology as well as the Campylobacter Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Campylobacter Infections market report provides current treatment practices, emerging drugs, Campylobacter Infections market share of the individual therapies, and current and forecasted Campylobacter Infections market size…
Bacteriophage Therapy Market (Phage Therapy Market; Virus: Campylobacter, Salmon …
The Global Bacteriophage Therapy Market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2030. Phage therapy or bacteriophage therapy uses viruses to treat pathogenic infections. A virus is also known as phages or bacteria eaters. In phage therapy, the virus only attacks the bacteria and is harmless to the host human, plant, or animal. In simple terms, bacteriophages are the natural enemies of bacteria…
Food Pathogen Testing Market Report 2018: Segmentation by Type (E.coli, Salmonel …
Global Food Pathogen Testing market research report provides company profile for R&D institutes, SGS, Bureau Veritas, Intertek, Eurofins, pathogen and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Campylobacter Diagnostics Market to See Incredible Growth During 2025
Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables. Major symptoms of campylobacter infection include diarrhea, blood and mucus in stool, malaise, severe abdominal pain, nausea, fever, vomiting, and headache. On average, campylobacter infection lasts from two to 10 days. Campylobacter infection is diagnosed through laboratory tests of stool, body…
Food Safety Testing Market Globally will be close to US$ 7 Billion by the year 2 …
For More Information:
http://www.renub.com/global-food-safety-testing-market-nd.php
Get Free Customization in This Report
By the year 2024, Global Food Safety Testing Market is US$ 7 Billion opportunities. When we say food safety it is a matter of concern because food is what we consume it impacts our body. If we do not eat right or hygienic foods, it will cause health to detoriate. Nowadays, many foodborne diseases are spreading due to the unhygienic foods…
Campylobacter Diagnostics Market Size, Status and Forecast to 2025
Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables. Major symptoms of campylobacter infection include diarrhea, blood and mucus in stool, malaise, severe abdominal pain, nausea, fever, vomiting, and headache. On average, campylobacter infection lasts from two to 10 days. Campylobacter infection is diagnosed through laboratory tests of stool, body…